Diabetes 50:955-961, 2001
© 2001 by the American Diabetes Association, Inc.
Insulin and Leptin Acutely Regulate Cholesterol Ester Metabolism in Macrophages by Novel Signaling Pathways
Lisa ORourke1,
Steven J. Yeaman2, and
Peter R. Shepherd1
1 Department of Biochemistry and Molecular Biology, University College London, London
2 School of Biochemistry and Genetics, University of Newcastle-upon-Tyne, Newcastle-upon-Tyne, U.K.
Leptin is produced in adipose tissue and acts in the hypothalamus to regulate food intake. However, recent evidence also indicates a potential for direct roles for leptin in peripheral tissues, including those of the immune system. In this study, we provide direct evidence that macrophages are a target tissue for leptin. We found that J774.2 macrophages express the functional long form of the leptin receptor (ObRb) and that this becomes tyrosine-phosphorylated after stimulation with low doses of leptin. Leptin also stimulates both phosphoinositide 3-kinase (PI 3-kinase) activity and tyrosine phosphorylation of JAK2 and STAT3 in these cells. We investigated the effects of leptin on hormone-sensitive lipase (HSL), which acts as a neutral cholesterol esterase in macrophages and is a rate-limiting step in cholesterol ester breakdown. Leptin significantly increased HSL activity in J774.2 macrophages, and these effects were additive with the effects of cAMP and were blocked by PI 3-kinase inhibitors. Conversely, insulin inhibited HSL in macrophages, but unlike adipocytes, this effect did not require PI 3-kinase. These results indicate that leptin and insulin regulate cholesterol-ester homeostasis in macrophages and, therefore, defects in this process caused by leptin and/or insulin resistance could contribute to the increased incidence of atherosclerosis found associated with obesity and type 2 diabetes.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. Bjorbaek and B. B. Kahn
Leptin Signaling in the Central Nervous System and the Periphery
Recent Prog. Horm. Res.,
January 1, 2004;
59(1):
305 - 331.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
F. Maingrette and G. Renier
Leptin Increases Lipoprotein Lipase Secretion by Macrophages: Involvement of Oxidative Stress and Protein Kinase C
Diabetes,
August 1, 2003;
52(8):
2121 - 2128.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Rahmouni, W. G. Haynes, D. A. Morgan, and A. L. Mark
Intracellular Mechanisms Involved in Leptin Regulation of Sympathetic Outflow
Hypertension,
March 1, 2003;
41(3):
763 - 767.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Shamir, N. Shehadeh, M. Rosenblat, O. Eshach-Adiv, R. Coleman, M. Kaplan, S. Hamoud, S. Lischinsky, and T. Hayek
Oral Insulin Supplementation Attenuates Atherosclerosis Progression in Apolipoprotein E-Deficient Mice
Arterioscler. Thromb. Vasc. Biol.,
January 1, 2003;
23(1):
104 - 110.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. O'Rourke, L. M. Gronning, S. J. Yeaman, and P. R. Shepherd
Glucose-dependent Regulation of Cholesterol Ester Metabolism in Macrophages by Insulin and Leptin
J. Biol. Chem.,
November 1, 2002;
277(45):
42557 - 42562.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. B. Kraemer and W.-J. Shen
Hormone-sensitive lipase: control of intracellular tri-(di-)acylglycerol and cholesteryl ester hydrolysis
J. Lipid Res.,
October 1, 2002;
43(10):
1585 - 1594.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. B. CEDDIA, H. A. KOISTINEN, J. R. ZIERATH, and G. SWEENEY
Analysis of paradoxical observations on the association between leptin and insulin resistance
FASEB J,
August 1, 2002;
16(10):
1163 - 1176.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. E. Wold, D. P. Relling, J. Duan, F. L. Norby, and J. Ren
Abrogated Leptin-Induced Cardiac Contractile Response in Ventricular Myocytes Under Spontaneous Hypertension: Role of JAK/STAT Pathway
Hypertension,
January 1, 2002;
39(1):
69 - 74.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Sweeney, J. Keen, R. Somwar, D. Konrad, R. Garg, and A. Klip
High Leptin Levels Acutely Inhibit Insulin-Stimulated Glucose Uptake without Affecting Glucose Transporter 4 Translocation in L6 Rat Skeletal Muscle Cells
Endocrinology,
November 1, 2001;
142(11):
4806 - 4812.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Diabetes Association.
|
|
| |
|